Tecnogen S.p.A.
Records under this name other than patents Tecnogen S.p.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,989,171 | Anti-human tenascin monoclonal antibody Formerly held Lapsed on the fee record Ended Aug 2, 2023 · From the USPTO record | Lapsed on the fee record | Ended Aug 2, 2023 | From the USPTO record |
| US 8,883,446 | Human long pentraxin 3 expression system and uses thereof Formerly held Lapsed on the fee record Ended Nov 11, 2022 · From the USPTO record | Lapsed on the fee record | Ended Nov 11, 2022 | From the USPTO record |
| US 8,268,304 | Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases Formerly held Lapsed on the fee record Ended Sep 18, 2020 · From the USPTO record | Lapsed on the fee record | Ended Sep 18, 2020 | From the USPTO record |
| US 8,076,300 | FGF2-binding peptides and uses thereof Formerly held Lapsed on the fee record Ended Dec 13, 2019 · From the USPTO record | Lapsed on the fee record | Ended Dec 13, 2019 | From the USPTO record |
| US 7,910,092 | Use of the long pentraxin PTX3 for the prevention or treatment of viral diseases Formerly held Lapsed on the fee record Ended Mar 22, 2019 · From the USPTO record | Lapsed on the fee record | Ended Mar 22, 2019 | From the USPTO record |
| US 8,003,383 | Vector for efficient selection and/or maturation of an antibody and uses thereof Formerly held Surrendered on reissue Surrendered on reissue Apr 12, 2016 · From the USPTO record | Surrendered on reissue | Surrendered on reissue Apr 12, 2016 | From the USPTO record |
| US 6,566,077 | Peptide useful as a ligand Lapsed on the fee record Ended May 20, 2015 · From the USPTO record | Lapsed on the fee record | Ended May 20, 2015 | From the USPTO record |
| US 6,222,011 | Antigenic peptides Lapsed on the fee record Ended Apr 24, 2013 · From the USPTO record | Lapsed on the fee record | Ended Apr 24, 2013 | From the USPTO record |
| US 6,207,807 | Method for the separation and purification of immunoglobulins Lapsed on the fee record Ended Mar 27, 2013 · From the USPTO record | Lapsed on the fee record | Ended Mar 27, 2013 | From the USPTO record |
| US 6,426,401 | Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction Lapsed on the fee record Ended Jul 30, 2010 · From the USPTO record | Lapsed on the fee record | Ended Jul 30, 2010 | From the USPTO record |